Emerging Technologies and a Sustainable, Healthy, Just World
By Marcy Darnovsky and Jesse Reynolds,
Biodiversity: The Newsletter of the Consultative Group on Biological Diversity (Winter 2010)
| 02. 24. 2010
The Case of Human Reproductive and Genetic Technologies
Synthetic biology is the rapidly developing field devoted to engineering life from the ground up. It has recently generated headlines about startling applications such as the effort to artificially construct a living bacterium, molecule by molecule. But one of its leading practitioners doesn’t think the engineering of life will stop there. Stanford’ University’s Drew Endy recently told The New Yorker:
“What if we could liberate ourselves from the tyranny of evolution by being able to design our own offspring? Think about what happens when you really can print the genome of your offspring. You could start with your own sequence, of course, and mash it up with your partner, or as many partners as you like.”
Synthetic biology is just one of a set of powerful emerging technologies challenging efforts toward environmental sustainability, human health, and social justice. The on-going controversies surrounding genetically-modified crops are just the beginning. Biotech companies are now deploying cloned and genetically modified farm animals.
Nanotechnology, or manufacturing at the atomic scale, proposes to remake the world “from the bottom-up” and simple forms of nanotechnology...
Related Articles
Cathy Tie seems to be good at starting businesses but not so dedicated to maintaining them. CGS, like many others, first heard of her thanks to Caiwei Chen and Antonio Regalado in MIT Technology Review, May 2025, as the partner (perhaps bride) of the notorious Chinese scientist He Jiankui, described in the headline as “China’s Frankenstein.” He prefers “Chinese Darwin.” She ran his Twitter account for a while, contributing such gems as:
Get in luddite, we’re going gene editing...
By Laura DeFrancesco, Nature Biotechnology | 03.17.2026
The first gene editors designed to fix genetic lesions in mutation-agnostic ways are poised to enter the clinic. Tessera Therapeutics and Alltrna, two Flagship Pioneering-funded companies, are gearing up to test novel genetic medicines in humans. Tessera received regulatory clearance...
By Carolyn Riley Chapman and Nirvan Bhatia, Hastings Bioethics Forum | 03.12.2026
Last year, researchers saved an infant named KJ from a life-threatening rare metabolic disorder using a customized gene editing therapy. This was the first time that an individualized gene therapy was used to treat a human patient, and it has...
By Alexandra Marquez, NBC News | 03.13.2026
“Donald Trump” by Gage Skidmore is licensed under CC BY-SA 2.0
President Donald Trump on Thursday blamed “the genetics” of assailants in a string of recent attacks across the country. He made the comments after attacks at a...